|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000166387 |
Summary for PPFIBP2 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000166387 | Gene symbol | PPFIBP2 |
| Gene name | PPFIA binding protein 2 | |
| HGNC | 9250 | |
| Entrez ID | 8495 | |
| Gene type | protein_coding | |
| Synonyms | PPFIBP2|Cclp1 | |
| UniProtAcc | Q8ND30 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for PPFIBP2 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| PPFIBP2 | 3.11e+03 | -1.28e+00 | 3.31e-01 | -3.87e+00 | 1.09e-04 | 1.08e-03 | ESCA |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for PPFIBP2 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for PPFIBP2 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg14838970 | chr11:7512586 | CGI:chr11:7513323-7514496 | promoter | 6.94e-01 | 8.04e-01 | -2.72e+00 | 6.51e-03 | 2.26e-02 | -1.10e-01 |
| BRCA | cg23039189 | chr11:7512797 | CGI:chr11:7513323-7514496 | promoter | 2.43e-01 | 3.56e-01 | -2.35e+00 | 1.88e-02 | 3.42e-02 | -1.13e-01 |
| GBM | cg01842720 | chr11:7514656 | CGI:chr11:7513323-7514496 | promoter,gene body | 2.65e-01 | 3.66e-01 | -2.31e+00 | 2.11e-02 | 3.63e-02 | -1.00e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg01842720 | chr11:7514656 | CGI:chr11:7513323-7514496 | promoter,gene body | 3.17e-01 | 1.96e-01 | 5.19e+00 | 2.05e-07 | 9.22e-07 | 1.22e-01 |
| KIRC | cg15389338 | chr11:7514684 | CGI:chr11:7513323-7514496 | promoter,gene body | 2.31e-01 | 1.08e-01 | 5.75e+00 | 9.01e-09 | 6.67e-08 | 1.23e-01 |
| LUAD | cg23039189 | chr11:7512797 | CGI:chr11:7513323-7514496 | promoter | 2.10e-01 | 1.00e-01 | 3.02e+00 | 2.55e-03 | 4.27e-03 | 1.09e-01 |
| LUSC | cg14838970 | chr11:7512586 | CGI:chr11:7513323-7514496 | promoter | 4.15e-01 | 5.46e-01 | -2.86e+00 | 4.25e-03 | 7.22e-03 | -1.31e-01 |
| LUSC | cg01842720 | chr11:7514656 | CGI:chr11:7513323-7514496 | promoter,gene body | 2.83e-01 | 4.10e-01 | -3.31e+00 | 9.44e-04 | 2.50e-03 | -1.27e-01 |
| LUSC | cg10253640 | chr11:7514752 | CGI:chr11:7513323-7514496 | promoter,gene body | 3.01e-01 | 4.10e-01 | -2.55e+00 | 1.07e-02 | 1.46e-02 | -1.09e-01 |
| CHOL | cg14838970 | chr11:7512586 | CGI:chr11:7513323-7514496 | promoter | 5.98e-01 | 3.69e-01 | 2.88e+00 | 4.04e-03 | 1.47e-02 | 2.29e-01 |
| CHOL | cg23039189 | chr11:7512797 | CGI:chr11:7513323-7514496 | promoter | 3.01e-01 | 6.46e-02 | 3.10e+00 | 1.96e-03 | 1.07e-02 | 2.36e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg14838970 | chr11:7512586 | CGI:chr11:7513323-7514496 | promoter | 6.94e-01 | 4.48e-01 | 1.34e+01 | 3.49e-41 | 3.70e-39 | 2.46e-01 |
| BRCA | cg23039189 | chr11:7512797 | CGI:chr11:7513323-7514496 | promoter | 2.43e-01 | 8.28e-02 | 1.13e+01 | 1.44e-29 | 2.00e-28 | 1.60e-01 |
| BRCA | cg15389338 | chr11:7514684 | CGI:chr11:7513323-7514496 | promoter,gene body | 3.15e-01 | 1.74e-01 | 6.82e+00 | 9.30e-12 | 2.65e-11 | 1.41e-01 |
| LIHC | cg14838970 | chr11:7512586 | CGI:chr11:7513323-7514496 | promoter | 5.57e-01 | 3.76e-01 | 4.45e+00 | 8.68e-06 | 6.18e-05 | 1.81e-01 |
| KIRP | cg10253640 | chr11:7514752 | CGI:chr11:7513323-7514496 | promoter,gene body | 3.35e-01 | 1.86e-01 | 2.47e+00 | 1.35e-02 | 2.06e-02 | 1.49e-01 |
Top |
Exon skipping events with PSI in TCGA for PPFIBP2 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for PPFIBP2 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for PPFIBP2 |
TFs related to PPFIBP2.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
PPFIBP2 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for PPFIBP2 |
RBPs related to ES in PPFIBP2.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| COAD | BRUNOL4 | exon_skip_56744 | 7.85e+00 | 8.50e-03 | 8.20e+00 | 9.84e-01 | Female-biased |
| COAD | BRUNOL5 | exon_skip_56744 | 7.87e+00 | 8.47e-03 | 8.22e+00 | 9.84e-01 | Female-biased |
| COAD | hnRNPLL | exon_skip_56744 | 7.76e+00 | 8.60e-03 | 8.11e+00 | 9.83e-01 | Female-biased |
| COAD | IGF2BP1 | exon_skip_56745 | 7.71e+00 | 1.14e-02 | 8.03e+00 | 9.80e-01 | Female-biased |
| LUAD | BRUNOL4 | exon_skip_56744 | 8.21e+00 | 9.82e-01 | 7.89e+00 | 1.06e-02 | Male-biased |
| LUAD | BRUNOL5 | exon_skip_56744 | 8.23e+00 | 9.82e-01 | 7.90e+00 | 1.07e-02 | Male-biased |
| LUAD | hnRNPLL | exon_skip_56744 | 8.12e+00 | 9.81e-01 | 7.80e+00 | 1.07e-02 | Male-biased |
| CHOL | ZCRB1 | exon_skip_56745 | 1.07e+01 | 4.28e-03 | 1.12e+01 | 9.95e-01 | Female-biased |
| READ | IGF2BP1 | exon_skip_56745 | 8.10e+00 | 9.86e-01 | 7.73e+00 | 6.05e-03 | Male-biased |
| READ | ZCRB1 | exon_skip_56745 | 1.07e+01 | 9.91e-01 | 1.03e+01 | 7.43e-03 | Male-biased |
| THCA | ESRP2 | exon_skip_56743 | 6.66e+00 | 3.02e-03 | 7.05e+00 | 9.84e-01 | Female-biased |
| THCA | SRSF9 | exon_skip_56739 | 8.12e+00 | 9.82e-01 | 7.83e+00 | 9.85e-03 | Male-biased |
| MESO | ZCRB1 | exon_skip_56745 | 1.07e+01 | 5.19e-03 | 1.11e+01 | 9.94e-01 | Female-biased |
| GBM | ZCRB1 | exon_skip_56745 | 1.05e+01 | 1.47e-03 | 1.10e+01 | 9.97e-01 | Female-biased |
| PAAD | IGF2BP1 | exon_skip_56745 | 7.72e+00 | 3.53e-03 | 8.10e+00 | 9.88e-01 | Female-biased |
| PAAD | ZCRB1 | exon_skip_56745 | 1.05e+01 | 1.15e-03 | 1.10e+01 | 9.98e-01 | Female-biased |
| KIRC | PCBP2 | exon_skip_56737 | 8.25e+00 | 9.85e-01 | 7.92e+00 | 7.49e-03 | Male-biased |
| HNSC | PCBP2 | exon_skip_56737 | 8.01e+00 | 9.54e-03 | 8.35e+00 | 9.83e-01 | Female-biased |
PPFIBP2 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs55909156 | chr11:13010964:G:C | - | 0.144641674897912 | 0.00672773530162608 | SARC | Female-baised eQTL |
| rs7126519 | chr11:7753585:A:T | - | -0.276195870951987 | 0.0279474131351707 | KIRP | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs59837266 | chr11:5496304:T:C | - | 0.0601334361867368 | 0.00967911460179462 | KIRC | Male-baised eQTL |
| rs73409984 | chr11:10488125:C:T | - | 0.0919169826136652 | 0.0108434881249868 | KIRC | Male-baised eQTL |
| rs60449395 | chr11:5493173:G:A | - | 0.0587720740146986 | 0.0136157033905078 | KIRC | Male-baised eQTL |
| rs76989783 | chr11:1997944:C:T | - | 0.0919191291109484 | 0.0137795915866104 | KIRC | Male-baised eQTL |
| rs10160740 | chr11:5495384:A:C | - | 0.0547734920822249 | 0.0266132658135948 | KIRC | Male-baised eQTL |
| rs56975454 | chr11:10478209:G:A | - | 0.0733130133601557 | 0.0333267398614615 | KIRC | Male-baised eQTL |
| rs147749225 | chr11:5478942:A:G | - | 0.0541074731048233 | 0.0340649734835414 | KIRC | Male-baised eQTL |
| rs59143167 | chr11:5492926:C:G | - | 0.0528296582723647 | 0.041138634665338 | KIRC | Male-baised eQTL |
| rs3891547 | chr11:10476112:G:C | - | 0.0711536357811427 | 0.0437073215866814 | KIRC | Male-baised eQTL |
| rs12577059 | chr11:5488459:T:C | - | 0.0511069569086484 | 0.0460870694515909 | KIRC | Male-baised eQTL |
| rs11038193 | chr11:5583483:A:T | - | 0.0554698388806532 | 0.00435806607525484 | BLCA | Male-baised eQTL |
| rs10742720 | chr11:5565067:T:C | - | 0.0531311976343675 | 0.0102185439864408 | BLCA | Male-baised eQTL |
| rs11022570 | chr11:12947644:C:G | - | 0.0688470481831721 | 0.0102813051468583 | BLCA | Male-baised eQTL |
| rs7130663 | chr11:12918845:G:A | - | 0.0741854761814887 | 0.012708334912335 | BLCA | Male-baised eQTL |
| rs780381 | chr11:9858809:G:A | - | -0.0805490541007563 | 0.0130971293002457 | BLCA | Male-baised eQTL |
| rs11022545 | chr11:12912136:G:A | - | 0.0862998397165466 | 0.0135920180022894 | BLCA | Male-baised eQTL |
| rs4369386 | chr11:12936071:A:C | - | 0.0689688442113169 | 0.0153111639127888 | BLCA | Male-baised eQTL |
| rs11606328 | chr11:5584265:A:T | - | 0.0511800833579176 | 0.0172043917288535 | BLCA | Male-baised eQTL |
| rs12281949 | chr11:5579198:T:G | - | -0.060131629068032 | 0.0176853450340558 | BLCA | Male-baised eQTL |
| rs56937920 | chr11:13092299:G:T | - | 0.103917045521867 | 0.0192283818379009 | BLCA | Male-baised eQTL |
| rs7124727 | chr11:9875392:G:T | - | -0.0748501499424267 | 0.0247569626967948 | BLCA | Male-baised eQTL |
| rs10838787 | chr11:1681699:G:A | - | 0.0499349434270638 | 0.0345323591166341 | BLCA | Male-baised eQTL |
| rs4417225 | chr11:1682334:C:T | - | 0.0499349434270638 | 0.0345323591166341 | BLCA | Male-baised eQTL |
| rs10838362 | chr11:5575900:C:T | - | -0.0576191552780693 | 0.0351111129400058 | BLCA | Male-baised eQTL |
| rs10838367 | chr11:5577430:A:T | - | -0.0572860273008208 | 0.0370120763303825 | BLCA | Male-baised eQTL |
| rs1530177 | chr11:12913422:A:C | - | 0.084797812104489 | 0.0392095937055738 | BLCA | Male-baised eQTL |
| rs4752780 | chr11:1680654:G:C | - | 0.0484648552618856 | 0.0431754121366615 | BLCA | Male-baised eQTL |
| rs10838369 | chr11:5577806:G:A | - | -0.0566980961039909 | 0.0450277258307018 | BLCA | Male-baised eQTL |
| rs10838370 | chr11:5577811:G:A | - | -0.0566980961039909 | 0.0450277258307018 | BLCA | Male-baised eQTL |
| rs6578627 | chr11:5385787:C:T | - | -0.1025256129995 | 0.0462121933666215 | BLCA | Male-baised eQTL |
| rs12802972 | chr11:1683366:G:A | - | 0.0479543304599227 | 0.046388342103933 | BLCA | Male-baised eQTL |
| rs4752781 | chr11:1680825:A:T | - | 0.0477564715718626 | 0.0482208926187274 | BLCA | Male-baised eQTL |
| rs11041688 | chr11:7953002:C:A | - | -0.0996514550865107 | 7.49479662140263e-05 | LUAD | Male-baised eQTL |
| rs10832508 | chr11:15730147:C:T | - | 0.123926376634701 | 0.000240330985894381 | LUAD | Male-baised eQTL |
| rs10832507 | chr11:15729482:G:A | - | 0.116682877181056 | 0.000581499486109918 | LUAD | Male-baised eQTL |
| rs11023692 | chr11:15726743:G:A | - | 0.116622776242686 | 0.000583244058004559 | LUAD | Male-baised eQTL |
| rs7107341 | chr11:15730807:T:A | - | 0.115930049957961 | 0.000657265338239085 | LUAD | Male-baised eQTL |
| rs1011824 | chr11:15725451:C:T | - | 0.116224771997965 | 0.000765321866176733 | LUAD | Male-baised eQTL |
| rs11023698 | chr11:15738579:C:T | - | 0.120598268091235 | 0.00129912113551152 | LUAD | Male-baised eQTL |
| rs7943117 | chr11:15727708:A:T | - | 0.106807743702579 | 0.00144679513590225 | LUAD | Male-baised eQTL |
| rs16931878 | chr11:15723404:T:C | - | 0.113191069733799 | 0.00223141820123158 | LUAD | Male-baised eQTL |
| rs4910542 | chr11:5191957:T:C | - | -0.115021319350908 | 0.00275098852824088 | LUAD | Male-baised eQTL |
| rs7948163 | chr11:7969136:G:T | - | -0.108123905328018 | 0.00593066522380802 | LUAD | Male-baised eQTL |
| rs11608118 | chr11:7959974:C:T | - | 0.109668252668861 | 0.0081935379754027 | LUAD | Male-baised eQTL |
| rs10832509 | chr11:15730660:G:T | - | 0.0912283976107862 | 0.0082410329280051 | LUAD | Male-baised eQTL |
| rs76598510 | chr11:5188561:C:A | - | 0.121807879196631 | 0.00859336930880503 | LUAD | Male-baised eQTL |
| rs7952115 | chr11:7946512:C:G | - | -0.109819665882517 | 0.0105282000863893 | LUAD | Male-baised eQTL |
| rs7121902 | chr11:15735249:A:C | - | 0.087890946767306 | 0.010797484426068 | LUAD | Male-baised eQTL |
| rs11023694 | chr11:15735997:G:A | - | 0.087890946767306 | 0.010797484426068 | LUAD | Male-baised eQTL |
| rs77505180 | chr11:5186320:G:T | - | 0.115755406289984 | 0.011858596256635 | LUAD | Male-baised eQTL |
| rs79822791 | chr11:5186594:C:G | - | 0.115755406289984 | 0.011858596256635 | LUAD | Male-baised eQTL |
| rs74370727 | chr11:5187208:G:A | - | 0.115319635691164 | 0.0124791328370637 | LUAD | Male-baised eQTL |
| rs77067422 | chr11:5190042:G:A | - | 0.114818354978888 | 0.0154835761219125 | LUAD | Male-baised eQTL |
| rs7939459 | chr11:5187163:A:G | - | -0.095075854064657 | 0.0155186760488469 | LUAD | Male-baised eQTL |
| rs6578566 | chr11:5186159:A:G | - | -0.0939670545323387 | 0.0169326093594828 | LUAD | Male-baised eQTL |
| rs6421045 | chr11:5186685:C:T | - | -0.0939670545323387 | 0.0169326093594828 | LUAD | Male-baised eQTL |
| rs6578569 | chr11:5187369:C:T | - | -0.0935366333612043 | 0.0179491765693334 | LUAD | Male-baised eQTL |
| rs7928916 | chr11:5188762:T:C | - | -0.0939543250077318 | 0.0198631393644187 | LUAD | Male-baised eQTL |
| rs7482952 | chr11:5187808:T:C | - | -0.092791288426479 | 0.0216137691323837 | LUAD | Male-baised eQTL |
| rs7479475 | chr11:5187875:C:T | - | -0.092791288426479 | 0.0216137691323837 | LUAD | Male-baised eQTL |
| rs7482378 | chr11:5187925:A:C | - | -0.092791288426479 | 0.0216137691323837 | LUAD | Male-baised eQTL |
| rs3959928 | chr11:15734002:T:A | - | 0.0813986460198899 | 0.0219940567352659 | LUAD | Male-baised eQTL |
| rs10832510 | chr11:15734839:G:C | - | 0.0813986460198899 | 0.0219940567352659 | LUAD | Male-baised eQTL |
| rs10832511 | chr11:15734967:T:C | - | 0.0813986460198899 | 0.0219940567352659 | LUAD | Male-baised eQTL |
| rs7129609 | chr11:15736583:A:G | - | 0.0813986460198899 | 0.0219940567352659 | LUAD | Male-baised eQTL |
| rs11023695 | chr11:15737341:T:C | - | 0.0813986460198899 | 0.0219940567352659 | LUAD | Male-baised eQTL |
| rs11023696 | chr11:15737368:A:G | - | 0.0813986460198899 | 0.0219940567352659 | LUAD | Male-baised eQTL |
| rs6486263 | chr11:15732376:A:G | - | 0.0813991818330125 | 0.024454596703447 | LUAD | Male-baised eQTL |
| rs11023693 | chr11:15732786:A:G | - | 0.08231239638273 | 0.0255497836690535 | LUAD | Male-baised eQTL |
| rs7938450 | chr11:15733394:A:T | - | 0.08231239638273 | 0.0255497836690535 | LUAD | Male-baised eQTL |
| rs9665778 | chr11:7943107:G:A | - | -0.103218415651479 | 0.0277515977239421 | LUAD | Male-baised eQTL |
| rs7113901 | chr11:15737203:G:C | - | 0.079493028237156 | 0.0282947496756517 | LUAD | Male-baised eQTL |
| rs79261994 | chr11:5176805:C:G | - | 0.116600494147432 | 0.0316662794010822 | LUAD | Male-baised eQTL |
| rs76219042 | chr11:5176816:G:A | - | 0.116600494147432 | 0.0316662794010822 | LUAD | Male-baised eQTL |
| rs77632769 | chr11:5176909:G:T | - | 0.116600494147432 | 0.0316662794010822 | LUAD | Male-baised eQTL |
| rs75753947 | chr11:5177005:C:T | - | 0.116600494147432 | 0.0316662794010822 | LUAD | Male-baised eQTL |
| rs4420243 | chr11:13092942:A:G | - | -0.132683893236917 | 0.0354163349477312 | LUAD | Male-baised eQTL |
| rs11023697 | chr11:15737622:A:G | - | 0.079063589128481 | 0.0354656163224381 | LUAD | Male-baised eQTL |
| rs10832512 | chr11:15738107:C:T | - | 0.0799600072566862 | 0.0367844155426244 | LUAD | Male-baised eQTL |
| rs10832513 | chr11:15738133:G:A | - | 0.0799600072566862 | 0.0367844155426244 | LUAD | Male-baised eQTL |
| rs1384023 | chr11:13188230:T:A | - | -0.0691507614627793 | 0.0370270429648929 | LUAD | Male-baised eQTL |
| rs11023700 | chr11:15739495:A:G | - | 0.0781107740850695 | 0.0404795514409563 | LUAD | Male-baised eQTL |
| rs11023701 | chr11:15739811:C:T | - | 0.0790436122642638 | 0.0417065319270563 | LUAD | Male-baised eQTL |
| rs6578568 | chr11:5186788:G:A | - | -0.0852858064657131 | 0.0448924099268226 | LUAD | Male-baised eQTL |
| rs75935256 | chr11:5690734:T:A | - | 0.0971321911931384 | 0.0112524069366738 | COAD | Male-baised eQTL |
| rs7938031 | chr11:8344601:C:T | - | 0.0486241162584095 | 0.0182788704794884 | COAD | Male-baised eQTL |
| rs59596795 | chr11:15579824:A:T | - | 0.0765881730999886 | 0.0348314663219089 | COAD | Male-baised eQTL |
| rs4757530 | chr11:17489209:G:A | - | 0.0506888774785901 | 0.0411820533326141 | COAD | Male-baised eQTL |
| rs112902971 | chr11:15251819:C:T | - | -0.0749824683777748 | 0.0460006159713274 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg17344055 | chr11:7586847 | gene | -0.469131057231619 | 1.13772600542244e-32 | -0.7437709575438697 | 1.1628429571843707e-36 | KIRP |
| cg25844590 | chr11:7600325 | gene | -0.469131057231619 | 1.13772600542244e-32 | -0.7437709575438697 | 1.1628429571843707e-36 | KIRP |
| cg05736186 | chr11:7612257 | gene | -0.263372033034664 | 1.1840630836467e-28 | -0.7120589623989445 | 2.1537380217495235e-32 | KIRP |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg16472904 | chr11:7576171 | gene | -0.148659568360302 | 2.35832075346284e-05 | -0.5160858037147843 | 7.378042031479691e-08 | LUSC |
| cg08119655 | chr11:7574694 | gene | -0.294628266500457 | 1.61790210085834e-05 | -0.3380273074088657 | 8.466485429470231e-08 | LGG |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of PPFIBP2 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000166387 | PPFIBP2 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| ENSG00000166387 | PPFIBP2 | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
| ENSG00000166387 | PPFIBP2 | C2931456 | Prostate cancer, familial | 1 | CTD_human |
| ENSG00000166387 | PPFIBP2 | C4722327 | PROSTATE CANCER, HEREDITARY, 1 | 1 | CTD_human |